132
Participants
Start Date
August 31, 2008
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
imatinib mesylate
Novartis Investigative Site, Taipei
Novartis Investigative Site, Tunis
Novartis Investigative Site, Parktown
Novartis Investigative Site, Taipei
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Riyadh
Novartis Investigative Site, Lin-Ko
Novartis Investigative Site, Taichung
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Songkhla
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Kursk
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Omsk
Novartis Investigative Site, Irkutsk
Novartis Investigative Site, Algiers
Novartis Investigative Site, Al Mansurah
Novartis Investigative Site, Cairo
Novartis Investigative Site, Amman
Novartis Investigative Site, Tainan City
Novartis Investigative Site, Pune
Novartis Investigative Site, Beirut
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY